Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 195 Records) |
| Query Trace: Neoplasms and Mut[original query] |
|---|
| Genomic Predictors Associated With Exceptional Response to Systemic Therapy in Advanced Pancreatic Cancer. Oncology (Williston Park, N.Y.) 2023 12 37 (12): 488-495. Suneel Kamath, Joanna Roopkumar, Ying Ni, Minqian Shen, Pablo Bejarano, Daniela Allende, Arun Nagarajan, Tim Nguyen, Bachar Dergham, Dale Shepard, Marc A Shapiro, Michael J McNamara, Bassam N Estfan, Kanika G Nair, Alok A Khora |
| Clinical features and prognostic biomarkers in patients with SMARCA4-mutated non-small cell lung cancer. Translational lung cancer research 2024 9 13 (8): 1938-1949. Jinyu Long, Ying Chen, Xingguang Luo, Ruiying Rao, Chenxi Wang, Yuxin Guo, Jinhe Xu, Ping Lin, Yingfang Song, Lijuan Qu, Qinghong Liu, Jun Lu, Chengzhi Zhou, Zhengbo Song, Xiandong Lin, Hiroyuki Adachi, Jacek Jassem, Masatsugu Hamaji, Zongyang |
| Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 8 JCO2400186. Paul Johannet, Somer Abdelfattah, Callahan Wilde, Shrey Patel, Henry Walch, Benoit Rousseau, Guillem Argiles, Oliver Artz, Miteshkumar Patel, Andrea Arfe, Andrea Cercek, Rona Yaeger, Karuna Ganesh, Nikolaus Schultz, Luis A Diaz, Michael B Foo |
| Genomic Profiling of Small Intestine Cancers From a Real-World Data Set Identifies Subgroups With Actionable Alterations. JCO precision oncology 2024 8 8 e2300425. Hiroyuki Takeda, Hiroyuki Yamamoto, Ritsuko Oikawa, Kumiko Umemoto, Hiroyuki Arai, Takuro Mizukami, Kazuki Ogawa, Yoshiyasu Uchida, Yusuke Nagata, Yohei Kubota, Ayako Doi, Yoshiki Horie, Takashi Ogura, Naoki Izawa, Jay A Moore, Ethan S Sokol, Yu Sunaka |
| Clinical and molecular features of early onset pancreatic adenocarcinoma. International journal of cancer 2024 8 . Maxime Rémond, Cristina Smolenschi, Anthony Tarabay, Maximiliano Gelli, Elena Fernandez-de-Sevilla, Ali Mouawia, Simona Cosconea, Lambros Tselikas, Remy Barbe, Alina Fuerea, Mohamed A Bani, Marc Deloger, Benjamin Besse, Thomas Pudlarz, Marine Valéry, Valérie Boige, Antoine Hollebecque, Michel Ducreux, Alice Boilè |
| Blood Tumor Mutational Burden Alone Is Not a Good Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Gastrointestinal Tumors. Journal of immunotherapy (Hagerstown, Md. : 1997) 2024 7 . James Yu, Robin Park, Ruoyu Miao, Iman Imanirad, Moazzam Shahzad, Jose M Laborde, Todd C Knepper, Christine M Walko, Richard K |
| Efficacy and Safety of Programmed Death 1/Programmed Death-Ligand 1 Plus Cytotoxic T-Lymphocyte-Associated Antigen 4 Inhibitors for Advanced or Metastatic Non-Small Cell Lung Cancer: A Meta-analysis Based on Randomized Controlled Trials. Therapeutic drug monitoring 2024 6 . Wei Ren, Yingying Fang, Yujing He, Yifeng Ren, Minfang Wang, Anyi Xu, Jiale Ruan, Qinghua T |
| Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms. British journal of cancer 2024 6 . Hege Elvebakken, Andreas Venizelos, Aurel Perren, Anne Couvelard, Inger Marie B Lothe, Geir O Hjortland, Tor Å Myklebust, Johanna Svensson, Herish Garresori, Christian Kersten, Eva Hofsli, Sönke Detlefsen, Lene W Vestermark, Stian Knappskog, Halfdan Sorb |
| Construction and analysis of a reliable five-gene prognostic signature for colon adenocarcinoma associated with the wild-type allelic state of the COL6A6 gene. Translational cancer research 2024 6 13 (5): 2475-2496. Qun Liu, Xiaohua Zhang, Yan Song, Junli Si, Zhaoshui Li, Quanjiang Do |
| Pan-cancer analysis of CDKN2A alterations identifies a subset of gastric cancer with a cold tumor immune microenvironment. Human genomics 2024 6 18 (1): 55. Chao Deng, Zi-Xi Li, Chen-Jun Xie, Qing-Lin Zhang, Ben-Shun Hu, Mei-Dan Wang, Jie Mei, Chen Yang, Zhangfeng Zhong, Ke-Wei Wa |
| MITO END-3: Efficacy of Avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy. Annals of oncology : official journal of the European Society for Medical Oncology 2024 5 . S Pignata, D Califano, D Lorusso, L Arenare, M Bartoletti, U De Giorgi, C Andreetta, C Pisano, G Scambia, D Lombardi, A Farolfi, S Cinieri, A Passarelli, V Salutari, C De Angelis, C Mignogna, D Priolo, E D Capoluongo, S Tamberi, G L Scaglione, V Arcangeli, R De Cecio, G Scognamiglio, F Greco, A Spina, M Turinetto, D Russo, V Carbone, C Casartelli, C Schettino, F Perro |
| The long and winding road to biomarkers for immunotherapy: a retrospective analysis of samples from patients with triple-negative breast cancer treated with pembrolizumab. ESMO open 2024 5 9 (5): 102964. L Buisseret, Y Bareche, D Venet, E Girard, A Gombos, P Emonts, S Majjaj, G Rouas, M Serra, V Debien, E Agostinetto, S Garaud, K Willard-Gallo, D Larsimont, J Stagg, F Rothé, C Sotiri |
| A comprehensive analysis of POLE/POLD1 genomic alterations in colorectal cancer. The oncologist 2024 5 . Osama Mosalem, Tucker W Coston, Robin Imperial, Elizabeth Mauer, Christopher Thompson, Binyam Yilma, Tanios S Bekaii-Saab, Melissa Conrad Stoppler, Jason S Sta |
| Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology 2024 5 . M Ambrosini, B Rousseau, P Manca, O Artz, A Marabelle, T André, G Maddalena, G Mazzoli, R Intini, R Cohen, A Cercek, N H Segal, L Saltz, A M Varghese, R Yaeger, M Nusrat, Z Goldberg, G Y Ku, I El Dika, O Margalit, A Grinshpun, P Kasi, R Schilsky, A Lutfi, E Shacham-Shmueli, M Khan Afghan, L Weiss, C B Westphalen, V Conca, B Decker, G Randon, E Elez, M Fakih, A B Schrock, C Cremolini, P Jayachandran, M J Overman, S Lonardi, F Pietranton |
| PCDH11X mutation as a potential biomarker for immune checkpoint therapies in lung adenocarcinoma. Journal of molecular medicine (Berlin, Germany) 2024 5 . Manjiao Liu, Meijia Yang, Bei Zhang, Sijian Xia, Jie Zhao, Linlin Yan, Yong Ren, Hao Guo, Jie Zh |
| Prognostic importance of prognostic nutritional index and modified Glasgow prognostic score in advanced lung cancer with targetable mutation. Journal of cancer research and clinical oncology 2024 4 150 (4): 215. Burak Bilgin, Yunus Kuralay, Sebnem Yuc |
| Discovery of recessive effect of human polymerase ? proofreading deficiency through mutational analysis of POLD1-mutated normal and cancer cells. European journal of human genetics : EJHG 2024 4 . Maria A Andrianova, Vladimir B Seplyarskiy, Mariona Terradas, Ana Beatriz Sánchez-Heras, Pilar Mur, José Luis Soto, Gemma Aiza, Emma Borràs, Fyodor A Kondrashov, Alexey S Kondrashov, Georgii A Bazykin, Laura Val |
| Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers. Communications medicine 2024 12 4 (1): 256. Reagan M Barnett, Albert Jang, Sree Lanka, PIngfu Fu, Leslie A Bucheit, Hani Babiker, Alan Bryce, Haley M Meyer, Yujin Choi, Casey Moore, Rohan Garje, Xin Gao, Dae Won Kim, Richard Y Chang, Pat Gulhati, Ryne Ramaker, Rani Bansal, Tian Zhang, A Oliver Sartor, Andrew J Armstrong, Mehmet A Bilen, Pedro Bara |
| The genomic landscape of cutaneous squamous cell carcinoma in Japan. The Journal of dermatology 2024 12 . Junji Kato, Tokimasa Hida, Masashi Idogawa, Takashi Tokino, Hisashi Uha |
| KRAS mutations in endometrial cancers: Possible prognostic and treatment implications. Gynecologic oncology 2024 11 191 299-306. Karolina A Kilowski, Martin F Dietrich, Joanne Xiu, Yasmine Baca, Andrew Hinton, Sarfraz Ahmad, Thomas J Herzog, Premal Thaker, Robert W Hollow |
| The molecular landscape of 227 adult granulosa cell tumors of the ovary: Insights into the progression from primary to recurrence. Laboratory investigation; a journal of technical methods and pathology 2024 11 102201. Romana Michálková, Adam Šafanda, Nikola Hájková, Jan Hojný, Eva Krkavcová, Michaela Kendall Bárt?, Marián Švajdler, Tetiana Shatokhina, Jan Laco, Radoslav Mat?j, Gábor Méhes, Jitka Hausnerová, Jozef Škarda, Mária Hácová, Monika Náležinská, Tomáš Zima, Pavel Dundr, Kristýna N?mejco |
| BRCA loss of function including BRCA1 DNA-methylation, but not BRCA-unrelated homologous recombination deficiency, is associated with platinum hypersensitivity in high-grade ovarian cancer. Clinical epigenetics 2024 11 16 (1): 171. Heidelinde Fiegl, Simon Schnaiter, Daniel U Reimer, Katharina Leitner, Petra Nardelli, Irina Tsibulak, Verena Wieser, Katharina Wimmer, Esther Schamschula, Christian Marth, Alain G Zeim |
| Integrated profile of tumor stage and mutational burden predicts disparate clinical responses to immune checkpoint inhibitors: A risk-benefit study. Seminars in oncology 2024 11 . Ming Zhe |
| Predictive value of ZFHX4 mutation for the efficacy of immune checkpoint inhibitors in non-small cell lung cancer and melanoma. Investigational new drugs 2024 10 . Cong Fu, Haoran Gu, Lin Sun, Zhouyu Wang, Qin Zhang, Ningning Luo, Dongsheng Chen, Tong Zh |
| Tumor mutational burden as a predictive biomarker for non-small cell lung cancer treated with immune checkpoint inhibitors of PD-1/PD-L1. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 1 . Min-Min Shao, Yue-Ping Xu, Jin-Jing Zhang, Mao Mao, Meng-Chuan Wa |
| GRIN2A mutation is a novel indicator of stratifying beneficiaries of immune checkpoint inhibitors in multiple cancers. Cancer gene therapy 2024 1 . Gan-Xun Li, Rui-Zhi Chang, Tong-Tong Liu, Guan-Nan Jin, Kan Lu, Tu-Ying Yong, Zifu Li, Ji-Hong Liu, Bixiang Zhang, Wan-Guang Zhang, Ze-Yang Di |
| Germline USP36 mutation confers resistance to EGFR-TKIs by upregulating MLLT3 expression in non-small cell lung cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 1 . Shaoxing Guan, Xi Chen, Yuru Wei, Fei Wang, Wen Xie, Youhao Chen, Heng Liang, Xia Zhu, Yunpeng Yang, Wenfeng Fang, Yan Huang, Hongyun Zhao, Xiaoxu Zhang, Shu Liu, Wei Zhuang, Min Huang, Xueding Wang, Li Zha |
| Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous Non-small-cell Lung Cancer. Clinical lung cancer 2024 1 . Laurent Mathiot, Benoit Nigen, Thomas Goronflot, Sandrine Hiret, Ludovic Doucet, Elvire Pons-Tostivint, Jaafar Bennouna, Marc G Denis, Guillaume Herbreteau, Judith Raimbou |
| Exploring co-occurring POLE exonuclease and non-exonuclease domain mutations and their impact on tumor mutagenicity. Cancer research communications 2024 1 . Shreya M Shah, Elena V Demidova, Salena Ringenbach, Bulat Faezov, Mark Andrake, Arjun Gandhi, Pilar Mur, Julen Viana-Errasti, Joanne Xiu, Jeffrey Swensen, Laura Valle, Roland L Dunbrack, Michael J Hall, Sanjeevani Aro |
| Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics. Cancers 2024 1 16 (1): . Qian Xi, Hidenori Kage, Miho Ogawa, Asami Matsunaga, Akira Nishijima, Kenbun Sone, Kei Kawana, Katsutoshi O |
- Page last reviewed:Feb 1, 2024
- Content source: